254 related articles for article (PubMed ID: 34425107)
1. USP2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates.
Zhang F; Zhao Y; Sun Y
J Biol Chem; 2021 Oct; 297(4):101109. PubMed ID: 34425107
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization.
Bashir T; Pagan JK; Busino L; Pagano M
Cell Cycle; 2010 Mar; 9(5):971-4. PubMed ID: 20160477
[TBL] [Abstract][Full Text] [Related]
5. TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.
Pavlides SC; Lecanda J; Daubriac J; Pandya UM; Gama P; Blank S; Mittal K; Shukla P; Gold LI
Cell Cycle; 2016; 15(7):931-47. PubMed ID: 26963853
[TBL] [Abstract][Full Text] [Related]
6. The role of SCF
Yamashita M; Owa T; Shiraishi R; Adachi T; Ichijo K; Taya S; Miyashita S; Hoshino M
Genes Cells; 2020 Dec; 25(12):796-810. PubMed ID: 33020978
[TBL] [Abstract][Full Text] [Related]
7. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Bashir T; Dorrello NV; Amador V; Guardavaccaro D; Pagano M
Nature; 2004 Mar; 428(6979):190-3. PubMed ID: 15014502
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection.
Wang W; Nacusi L; Sheaff RJ; Liu X
Biochemistry; 2005 Nov; 44(44):14553-64. PubMed ID: 16262255
[TBL] [Abstract][Full Text] [Related]
9. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
Uehara N; Yoshizawa K; Tsubura A
Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
[TBL] [Abstract][Full Text] [Related]
10. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I
J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183
[TBL] [Abstract][Full Text] [Related]
11. The NUCKS1-SKP2-p21/p27 axis controls S phase entry.
Hume S; Grou CP; Lascaux P; D'Angiolella V; Legrand AJ; Ramadan K; Dianov GL
Nat Commun; 2021 Nov; 12(1):6959. PubMed ID: 34845229
[TBL] [Abstract][Full Text] [Related]
12. FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation.
Jeong K; Murphy JM; Ahn EE; Lim SS
Cardiovasc Res; 2022 Mar; 118(4):1150-1163. PubMed ID: 33839758
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulations elucidate the mode of protein recognition by Skp1 and the F-box domain in the SCF complex.
Chandra Dantu S; Nathubhai Kachariya N; Kumar A
Proteins; 2016 Jan; 84(1):159-71. PubMed ID: 26573739
[TBL] [Abstract][Full Text] [Related]
14. Nuclear translocation of Skp2 facilitates its destruction in response to TGFβ signaling.
Hu D; Liu W; Wu G; Wan Y
Cell Cycle; 2011 Jan; 10(2):285-92. PubMed ID: 21212736
[TBL] [Abstract][Full Text] [Related]
15. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
Appleman LJ; Chernova I; Li L; Boussiotis VA
Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
[TBL] [Abstract][Full Text] [Related]
16. Melanoma antigen-A11 regulates substrate-specificity of Skp2-mediated protein degradation.
Su S; Chen X; Geng J; Minges JT; Grossman G; Wilson EM
Mol Cell Endocrinol; 2017 Jan; 439():1-9. PubMed ID: 27720894
[TBL] [Abstract][Full Text] [Related]
17. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
Bornstein G; Ganoth D; Hershko A
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
Lwin T; Hazlehurst LA; Dessureault S; Lai R; Bai W; Sotomayor E; Moscinski LC; Dalton WS; Tao J
Blood; 2007 Sep; 110(5):1631-8. PubMed ID: 17502456
[TBL] [Abstract][Full Text] [Related]
19. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
Gupta P; Zhao H; Hoang B; Schwartz EL
Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
[TBL] [Abstract][Full Text] [Related]
20. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase.
Li P; Li C; Zhao X; Zhang X; Nicosia SV; Bai W
J Biol Chem; 2004 Jun; 279(24):25260-7. PubMed ID: 15075339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]